Sobi - Swedish Orphan Biovitrum AB (publ)
Rare disease therapies access
- B2B
About Sobi - Swedish Orphan Biovitrum AB (publ)
Specialized biopharmaceutical company providing innovative therapies for rare diseases, with global presence and revenue of SEK 221 billion in 2023
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001–5,000 employees
- Headquarters
- Stockholm, Stockholm County, Sweden
- Revenue
- SEK 28.2BFY2025, publicly reported
- Website
- sobi.com
- linkedin.com/company/sobi
Jobs at Sobi - Swedish Orphan Biovitrum AB (publ)
Sobi - Swedish Orphan Biovitrum AB (publ) in the news
- Swedish Orphan Biovitrum AB (publ) (SOBI.ST) stock price, news, quote and history
Swedish Orphan Biovitrum AB (publ) is a biopharma company providing medicines in haematology, immunology, and specialty care with a global presence and various partnerships.
- Swedish Orphan Biovitrum AB (publ) (SOBI.ST) stock price, news, quote and history
Sobi is a biopharmaceutical company focused on developing and commercializing therapies in haematology, immunology, and specialty care globally.
- Swedish Orphan Biovitrum AB (publ) (OMXSTO:SOBI) Pays $75M As Innate Deal Becomes Effective
Sobi paid Innate Pharma $75 million as their strategic partnership became effective, granting Sobi exclusive global commercialization rights for lacutamab.
- Sobi and Innate announce partnership is now effective following completion of closing conditions
Sobi and Innate Pharma's strategic partnership is now effective, enabling the initiation of a Phase 3 study for lacutamab and granting Sobi global commercialisation rights.
- Sobi Receives US FDA Fast Track Designation for pacritinib in VEXAS Syndrome
Sobi's pacritinib received US FDA Fast Track designation for VEXAS syndrome, accelerating its development for this debilitating condition.
Sobi - Swedish Orphan Biovitrum AB (publ) at a glance
Sobi - Swedish Orphan Biovitrum AB (publ) is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Stockholm, Stockholm County, Sweden.
Sobi - Swedish Orphan Biovitrum AB (publ) has 1,001–5,000 employees.
Sobi - Swedish Orphan Biovitrum AB (publ)'s revenue is SEK 28.2B (FY2025, publicly reported).
Sobi - Swedish Orphan Biovitrum AB (publ) is hiring: 2 recent open roles, including Quality Supplier Manager GDP, IT Operations Manager - Full Stack Developer Azure & AI.
Selling to companies like Sobi - Swedish Orphan Biovitrum AB (publ)?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies